Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Inventory: 2019-2024

Historic Inventory for Eton Pharmaceuticals (ETON) over the last 6 years, with Dec 2024 value amounting to $15.2 million.

  • Eton Pharmaceuticals' Inventory rose 769.71% to $16.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.9 million, marking a year-over-year increase of 769.71%. This contributed to the annual value of $15.2 million for FY2024, which is 1572.01% up from last year.
  • Per Eton Pharmaceuticals' latest filing, its Inventory stood at $15.2 million for FY2024, which was up 1,572.01% from $911,000 recorded in FY2023.
  • In the past 5 years, Eton Pharmaceuticals' Inventory ranged from a high of $15.2 million in FY2024 and a low of $550,000 during FY2021.
  • Moreover, its 3-year median value for Inventory was $911,000 (2023), whereas its average is $5.6 million.
  • In the last 5 years, Eton Pharmaceuticals' Inventory crashed by 55.72% in 2021 and then surged by 1,572.01% in 2024.
  • Eton Pharmaceuticals' Inventory (Yearly) stood at $1.2 million in 2020, then slumped by 55.72% to $550,000 in 2021, then climbed by 1.27% to $557,000 in 2022, then spiked by 63.55% to $911,000 in 2023, then soared by 1,572.01% to $15.2 million in 2024.